Insider Stock Trading History of Sherman Matthew L


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Sherman Matthew L since year 2005. The trader's CIK number is 1325710. At the time of this reporting, Sherman Matthew L is the EVP & Chief Medical Officer of Acceleron Pharma Inc . (stock ticker symbol XLRN). See this page for all insider trading activities at Acceleron Pharma Inc .


Stock purchases, sales, and option exercises reported by insider Sherman Matthew L since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-01-03 XLRN Acceleron Pharma Inc Sale 4,633 42.20 195,498
2017-09-12 XLRN Acceleron Pharma Inc Sale 18,400 39.16 720,488
2017-07-05 XLRN Acceleron Pharma Inc Sale 16,000 32.00 512,000
2017-07-05 XLRN Acceleron Pharma Inc Option Ex 8,000 7.12 56,960
2017-01-04 XLRN Acceleron Pharma Inc Sale 2,000 27.21 54,430
2016-08-10 XLRN Acceleron Pharma Inc Option Ex 18,896 6.20 117,155
2016-07-07 XLRN Acceleron Pharma Inc Option Ex 6,000 5.28 31,680
2016-07-01 XLRN Acceleron Pharma Inc Sale 26,000 34.55 898,170
2016-07-01 XLRN Acceleron Pharma Inc Option Ex 14,000 4.75 66,458
2016-04-07 XLRN Acceleron Pharma Inc Option Ex 14,000 5.08 71,120
2016-04-06 XLRN Acceleron Pharma Inc Sale 2,080 32.00 66,560
2016-04-07 XLRN Acceleron Pharma Inc Sale 23,920 32.00 765,440
2015-10-15 XLRN Acceleron Pharma Inc Sale 6,000 23.30 139,830
2015-09-16 XLRN Acceleron Pharma Inc Sale 2,000 33.91 67,830
2015-08-24 XLRN Acceleron Pharma Inc Option Ex 20,000 3.88 77,600
2015-08-18 XLRN Acceleron Pharma Inc Option Ex 5,600 2.78 15,567
2015-08-18 XLRN Acceleron Pharma Inc Sale 7,000 31.39 219,751
2015-07-20 XLRN Acceleron Pharma Inc Option Ex 4,800 2.78 13,343
2015-07-20 XLRN Acceleron Pharma Inc Sale 6,000 32.76 196,536
2015-06-18 XLRN Acceleron Pharma Inc Option Ex 5,600 2.78 15,567
2015-06-18 XLRN Acceleron Pharma Inc Sale 7,000 31.40 219,821
2015-05-18 XLRN Acceleron Pharma Inc Option Ex 5,600 2.78 15,567
2015-05-18 XLRN Acceleron Pharma Inc Sale 7,000 32.30 226,135
2015-04-20 XLRN Acceleron Pharma Inc Sale 5,000 33.52 167,575
2015-04-20 XLRN Acceleron Pharma Inc Option Ex 4,000 .48 1,920
2015-04-16 XLRN Acceleron Pharma Inc Option Ex 12,000 3.88 46,560
2015-03-18 XLRN Acceleron Pharma Inc Option Ex 4,800 2.78 13,343
2015-03-18 XLRN Acceleron Pharma Inc Sale 6,000 41.31 247,848
2015-03-04 XLRN Acceleron Pharma Inc Option Ex 5,600 2.78 15,567
2015-03-04 XLRN Acceleron Pharma Inc Sale 7,000 41.04 287,273
2015-01-20 XLRN Acceleron Pharma Inc Option Ex 5,600 2.78 15,567
2015-01-20 XLRN Acceleron Pharma Inc Sale 7,000 41.62 291,368
2014-12-18 XLRN Acceleron Pharma Inc Sale 5,000 40.31 201,535
2014-12-17 XLRN Acceleron Pharma Inc Option Ex 2,000 3.88 7,760
2014-12-18 XLRN Acceleron Pharma Inc Option Ex 4,000 .48 1,920
2014-12-10 XLRN Acceleron Pharma Inc Option Ex 4,000 5.08 20,320
2014-12-10 XLRN Acceleron Pharma Inc Sale 5,000 43.52 217,615
2014-11-18 XLRN Acceleron Pharma Inc Option Ex 4,082 .48 1,959
2014-11-18 XLRN Acceleron Pharma Inc Sale 5,082 34.00 172,803
2014-11-12 XLRN Acceleron Pharma Inc Option Ex 3,918 3.44 13,477
2014-11-12 XLRN Acceleron Pharma Inc Sale 4,918 33.09 162,736
2014-10-20 XLRN Acceleron Pharma Inc Sale 4,918 29.11 143,162
2014-10-08 XLRN Acceleron Pharma Inc Option Ex 4,082 1.80 7,347
2014-10-08 XLRN Acceleron Pharma Inc Sale 5,082 29.78 151,357
2014-09-18 XLRN Acceleron Pharma Inc Sale 5,000 25.48 127,425
2014-09-03 XLRN Acceleron Pharma Inc Sale 5,000 26.00 129,985
2014-09-03 XLRN Acceleron Pharma Inc Option Ex 4,000 1.80 7,200
2014-08-18 XLRN Acceleron Pharma Inc Sale 2,500 29.77 74,412
2014-08-14 XLRN Acceleron Pharma Inc Option Ex 6,000 1.14 6,839
2014-08-14 XLRN Acceleron Pharma Inc Sale 7,500 29.95 224,602
2014-08-12 XLRN Acceleron Pharma Inc Option Ex 8,000 1.80 14,400
2014-07-23 XLRN Acceleron Pharma Inc Option Ex 10,000 1.80 18,000
2014-07-18 XLRN Acceleron Pharma Inc Sale 2,500 26.22 65,557
2014-07-09 XLRN Acceleron Pharma Inc Sale 7,500 29.04 217,815
2014-07-09 XLRN Acceleron Pharma Inc Option Ex 6,000 .48 2,880
2014-06-18 XLRN Acceleron Pharma Inc Sale 2,500 34.31 85,775
2014-06-11 XLRN Acceleron Pharma Inc Sale 7,500 33.24 249,300
2014-06-11 XLRN Acceleron Pharma Inc Option Ex 6,000 .48 2,880
2014-05-28 XLRN Acceleron Pharma Inc Option Ex 6,000 .48 2,880
2014-05-28 XLRN Acceleron Pharma Inc Sale 7,500 30.98 232,350
2014-05-19 XLRN Acceleron Pharma Inc Sale 2,500 31.79 79,482
2014-04-22 XLRN Acceleron Pharma Inc Sale 5,000 35.82 179,115

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sherman Matthew L (EVP & Chief Medical Officer of Acceleron Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.